Somnomed Limited · ASX:SOM
Somnomed — H1 FY2013 Earnings Presentation
13 slides from Somnomed's earnings presentation, Feb 28, 2013
Slide 1: Investor Presentation Half year to 31 December 2012
For personal use only INVESTOR PRESENTATION Half year to 31 December 2012 FY 2012 - 2013 Dr Peter Neustadt (Executive Chairman) Dr Kien Nguyen (President SomnoMed Inc.) Mr Neil Verdal-Austin (CFO) This presentation contains forward-looking statements that involve risks and uncertainties. These forwa
Slide 2: Disclaimer & Regulatory Disclosure
Disclaimer & Regulatory Disclosure For personal use only This document has been prepared as a summary only, and does not contain all information about the Company’s assets and liabilities, financial position and performance, profit and losses and the rights and liabilities attaching to the Company’s
Slide 3: Financial Highlights and Achievements: First Half FY2012/13
Financial Highlights and Achievements : First Half FY2012/13 For personal use only 1 2 3 4 5 Revenues = SomnoDent® EBITDA = $723k Main Continued strong $9.026 million Units sold = (+194% Yr on Yr) Achievements underlying (+32% Yr on Yr) 17182 units First Half business and (+19% Yr on Yr) disciplined
Slide 4: Continuing strong quarterly growth
Continuing strong quarterly growth For personal use only Global Units Sold Steady Regional Distribution 35,000 G2 30,000 25,000 APAC 12% 20,000 Europe USA 28% 60% 15,000 Flex 10,000 Classic 5,000 Licensee 0 2007 2008 2009 2010 2011 2012 © SomnoMed 2013 4
Slide 5: Half Year Comparison at December 2012 vs 2011
Half Year Comparison at December 2012 vs 2011 For personal use only +32% +32% +51% +194% © SomnoMed 2013 5
Slide 6: Summary Financial Results
Summary Financial Results For personal use only Financial Summary ($000's) 12/13 11/12 10/11 09/10 08/09 07/08 06/07 1st H 1st H 1st H 1st H 1st H 1st H 1st H Units 17,182 14,443 11,450 9,140 5,475 2,916 1,870 Revenue 9,026 6,846 5,975 4,989 3,180 1,497 1,104 Gross Margin 5,962 4,515 3,825 2,847 1,6
Slide 7: Cash Flow
Cash Flow For personal use only | Closely managed and tightly controlled | Half year closed at the same cash held at 30 June 2012 ($3.535 million) despite growth and additional costs of +$400k: – Growth in underlying business – Acquisition of Orthosom and related costs in France & pre-acquisition co
Slide 8: North America – Year Unit Sales Growth
North America – 5 Year Unit Sales Growth For personal use only © SomnoMed 2013 8
Slide 9: US Market Opportunity
US Market Opportunity For personal use only SomnoDent® ~2 million new patients * Volume market share +20% * Value market share +30% diagnosed with sleep apnea ~175K Dentists ~5,000 Board ~8-10K treat sleep Certified Sleep ~1.7 million ~100K patients Physicians CPAP custom made prescribed OAT ~2,500
Slide 10: North America – Building Key Components of SomnoMed Medical Initiative
North America – Building Key Components of SomnoMed Medical Initiative to dominate US activities over next 3 years For personal use only | Building broader medical acceptance l Clinical data l CMO/MAB l MATRx l Compliance measurement l Medical education program | Increasing referrals of patients for
Slide 11: North American Management Team
North American Management Team For personal use only Kien Nguyen President Stephanie Wolff Maribelle Velasco Felix Silva Stacey Gilbert Andrew Tosdevin To Be Appointed Kathryn Jayne VP Finance & Admin VP Dental Operations Manager VP Managed Care VP Sales & Marketing CMO Manager QA/RA Medical Focus ©
Slide 12: The Second Half Outlook
The Second Half Outlook For personal use only | SomnoDent® G2 roll out to gain momentum | Continued strong growth in Europe and steady growth in APAC | US direct sales swinging back to expected levels | Start of medical initiatives and expansion of MATRx fitted labs | Revenues likely to reach $20m f
Slide 13: For personal use only
For personal use only EXECUTIVE CHAIRMAN Dr Peter Neustadt CHIEF FINANCIAL OFFICER Mr Neil Verdal–Austin Address Level 3, 20 Clarke Street Crows Nest NSW 2065 Australia Telephone +61 (2) 9467 0400 Website www.somnomed.com.au